Related references
Note: Only part of the references are listed.Metabolic modulation of cancer: a new frontier with great translational potential
Adam Kinnaird et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate
Rakesh K. Pathak et al.
ACS CHEMICAL BIOLOGY (2014)
A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation
Gopinath Sutendra et al.
CELL (2014)
SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells
Ozkan Ozden et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Structure-guided Development of Specific Pyruvate Dehydrogenase Kinase Inhibitors Targeting the ATP-binding Pocket
Shih-Chia Tso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect
Jun Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth
Changliang Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90
Tao Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Comprehensive review on lactate metabolism in human health
M. Adeva-Andany et al.
MITOCHONDRION (2014)
Tyr Phosphorylation of PDP1 Toggles Recruitment between ACAT1 and SIRT3 to Regulate the Pyruvate Dehydrogenase Complex
Jun Fan et al.
MOLECULAR CELL (2014)
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells
Jonathan D. Moore et al.
ONCOTARGET (2014)
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
Y-C Shen et al.
BRITISH JOURNAL OF CANCER (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
SIRT5-Mediated Lysine Desuccinylation Impacts Diverse Metabolic Pathways
Jeongsoon Park et al.
MOLECULAR CELL (2013)
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon et al.
NATURE (2013)
Mitochondrial activation by inhibition of PDKII suppresses HIF1α signaling and angiogenesis in cancer
G. Sutendra et al.
ONCOGENE (2013)
Phenylbutyrate Therapy for Pyruvate Dehydrogenase Complex Deficiency and Lactic Acidosis
Rosa Ferriero et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Clinical and Experimental Applications of Sodium Phenylbutyrate
Tommaso Iannitti et al.
Drugs in research & development (2013)
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Tanupriya Contractor et al.
CANCER RESEARCH (2012)
Glucose Oxidation Modulates Anoikis and Tumor Metastasis
Sushama Kamarajugadda et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer
Chun-Wun Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation
Alexandra R. Grassian et al.
GENES & DEVELOPMENT (2011)
Anticancer drugs that target metabolism: is dichloroacetate the new paradigm?
Ioanna Papandreou et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex
Jean-Marc Blouin et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo
Zuzana Zachar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Tyrosine Phosphorylation of Mitochondrial Pyruvate Dehydrogenase Kinase 1 Is Important for Cancer Metabolism
Taro Hitosugi et al.
MOLECULAR CELL (2011)
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
Ramon C. Sun et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
Kathryn E. Wellen et al.
SCIENCE (2009)
Role of dichloroacetate in the treatment of genetic mitochondrial diseases
Peter W. Stapoole et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
E. D. Michelakis et al.
BRITISH JOURNAL OF CANCER (2008)
Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity
R. Max Wynn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Regulation of the PDK4 isozyme by the Rb-E2F1 complex
Michael C. F. Hsieh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells
Thomas McFate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance
Chun-Wun Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Structural Basis for Inactivation of the Human Pyruvate Dehydrogenase Complex by Phosphorylation: Role of Disordered Phosphorylation Loops
Masato Kato et al.
STRUCTURE (2008)
Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy
Sam E. Day et al.
NATURE MEDICINE (2007)
Energizing miRNA research: A review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways
Bernard R. Wilfred et al.
MOLECULAR GENETICS AND METABOLISM (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer
T. E. Roche et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
Heidi Lyng et al.
BMC GENOMICS (2006)
Regulation of the pyruvate dehydrogenase complex
MS Patel et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands
TR Knoechel et al.
BIOCHEMISTRY (2006)
Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP
HY Bao et al.
BIOCHEMISTRY (2004)
Structure of pyruvate dehydrogenase kinase - Novel folding pattern for a serine protein kinase
CN Steussy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tumor grade, microvessel density, and activities of malate dehydrogenase, lactate dehydrogenase, and hexokinase in squamous cell carcinoma
CD Ross et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2000)
Share Paper
